Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
Stock data | 2023 | Change |
---|---|---|
Price | $8.61 | N/A |
Market Cap | $209.19M | N/A |
Shares Outstanding | 24.30M | 0.03% |
Employees | 1.62K | N/A |
Shareholder Equity | 41.17B | 15.00% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.06 | N/A |
P/S Ratio | 0.73 | N/A |
P/B Ratio | 0.01 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0006 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $286.63M | N/A |
Earnings | $24.08M | N/A |
EPS | 141.37 | N/A |
Earnings Yield | 16.42 | N/A |
Gross Margin | 0.4039 | N/A |
Operating Margin | 0.0945 | N/A |
Net income margin | 0.084 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $598.15M | N/A |
Total Debt | $202.92M | N/A |
Cash on Hand | $16.29M | N/A |
Debt to Equity | 0.0075 | -3.37% |
Cash to Debt | 0.0803 | -44.38% |
Current Ratio | $1.31 | -9.30% |